Federation Des Caisses Desjardins Du Quebec Alkermes Plc. Call Options Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
385Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$789 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$501 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$332 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$239 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$205 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.45B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...